BHBIA & MEMBER NEWS

Back to News List

MEMBER NEWS

CTO Appointment reflects importance of technology innovation at HCP Insights Consultancy

March 8th, 2022

CREATION.co, one of the world’s leading consultancies for insights-led health strategy, is delighted to announce the appointment of a new CTO role within the company, as the business continues to drive forward with world-class technology & innovation.

Greg Hall has recently joined as Chief Technology Officer and will oversee the technology and software division across the global team. Greg’s appointment recognises the importance of innovation within this space and highlights CREATION.co’s strategic priority for technology over the next few years.

Prior to joining CREATION.co, Greg has worked in both global corporations and ‘start up’ companies, across a range of financial services and Fintech industry. He has a passion for technology and over 25 years experience in software development, including building and leading development teams, systems design and architecture, agile methodologies and business leadership. He has worked with a wide range of technology and maintains a ‘hands on’ and pragmatic approach.

Greg is a Chartered IT Professional and a Fellow of both the British Computer Society and the Institution of Analysts and Programmers.

Commenting on the appointment, Daniel Ghinn, CEO and Founder of CREATION.co said:

“Since we started, CREATION.co has been trusted for our industry-leading technology innovation. CREATION Pinpoint is the world’s only AI-powered global database of more than 3 million healthcare professionals’ social media profiles. Over the last 5 years, we have seen the business grow, and we now work with most of the top 20 pharmaceutical companies. We are involved with delivering some of the most exciting data-led insights to teams around the world that are driving strategic decisions within healthcare at a global level.

As we have grown our insights-led health strategy business, we have continued to invest in new innovations in our products. Greg’s appointment will super-charge this approach and our commitment to R&D to serve our healthcare clients better than anyone else in the world.”